Literature DB >> 1523580

Cardiopathic effects of dichloroacetate in the fetal Long-Evans rat.

D L Epstein1, G A Nolen, J L Randall, S A Christ, E J Read, J A Stober, M K Smith.   

Abstract

Dichloroacetic acid (DCA) is a by-product of the chlorine disinfection of water and may occur in treated water at levels exceeding 100 micrograms/L. Previous studies revealed teratogenic effects, particularly heart malformations, at high doses (900-2,400 mg/kg given on days 6-15 of pregnancy). In a series of three studies, groups of 7-10 Long-Evans rats were dosed with 1,900 mg/kg of DCA on days 6-8, 9-11, or 12-15; with 2,400 mg/kg on days 10, 11, 12, or 13; and with 3,500 mg/kg on days 9, 10, 11, 12, or 13, in an attempt to determine the most sensitive period and further characterize the heart defect. In a fourth study, six dams were treated with 1,900 mg/kg of DCA days 6-15 of pregnancy, and 56 fetuses were harvested for light microscopy of the heart. Eight control fetuses from four litters were also examined. No heart malformations were seen in the groups treated with 1,900 mg/kg DCA days 6-8 but were present in the group treated on days 9-11 and 12-15, with the higher incidence occurring on days 12-15. Single doses of 2,400 mg/kg DCA given on days 10, 11, 12, or 13 resulted in a much lower incidence of cardiac malformations, which occurred only on days 10 and 12. The high dose of DCA (3,500 mg/kg) did not increase the incidence of heart defects but showed that dosing on day 9 as well as on days 10 and 12 would produce the defect. The defects seen were characterized as high interventricular septal defects (H-IVSD). Light microscopy showed that the defect was caudal to the semilunar valves, with the anterior right wall of the aorta communicating with the right ventricle. Another aspect of the defect is at the level of the semilunar valves, with the right cusp or sinus of Valsalva in communication with the right ventricle. The defects are discussed more fully and methods for further study suggested.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1523580     DOI: 10.1002/tera.1420460306

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  7 in total

1.  Relation between trihalomethane compounds and birth defects.

Authors:  L Dodds; W D King
Journal:  Occup Environ Med       Date:  2001-07       Impact factor: 4.402

Review 2.  Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.

Authors:  H A Barton; H J Clewell
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

3.  Role of Risk of Bias in Systematic Review for Chemical Risk Assessment: A Case Study in Understanding the Relationship Between Congenital Heart Defects and Exposures to Trichloroethylene.

Authors:  Daniele Wikoff; Jon D Urban; Seneca Harvey; Laurie C Haws
Journal:  Int J Toxicol       Date:  2018-01-22       Impact factor: 2.032

4.  Targeted Metabolomic Assessment of the Sub-Lethal Toxicity of Halogenated Acetic Acids (HAAs) to Daphnia magna.

Authors:  Lisa M Labine; Myrna J Simpson
Journal:  Metabolites       Date:  2021-02-10

Review 5.  A systematic evaluation of the potential effects of trichloroethylene exposure on cardiac development.

Authors:  Susan L Makris; Cheryl Siegel Scott; John Fox; Thomas B Knudsen; Andrew K Hotchkiss; Xabier Arzuaga; Susan Y Euling; Christina M Powers; Jennifer Jinot; Karen A Hogan; Barbara D Abbott; E Sidney Hunter; Michael G Narotsky
Journal:  Reprod Toxicol       Date:  2016-08-27       Impact factor: 3.421

6.  The effect of disinfection by-products and mutagenic activity on birth weight and gestational duration.

Authors:  J Michael Wright; Joel Schwartz; Douglas W Dockery
Journal:  Environ Health Perspect       Date:  2004-06       Impact factor: 9.031

7.  Disinfection By-Product Exposures and the Risk of Specific Cardiac Birth Defects.

Authors:  J Michael Wright; Amanda Evans; John A Kaufman; Zorimar Rivera-Núñez; Michael G Narotsky
Journal:  Environ Health Perspect       Date:  2016-08-12       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.